Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Early diagnosis and aggressive treatment of lupus nephritis can prevent kidney damage and improve outcomes.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

A woman experienced unusual hair loss and skin reactions after taking phenobarbital, but her hair grew back after treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Mogamulizumab can cause hair loss and skin rashes.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Baricitinib works better than methotrexate for severe alopecia areata.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

Nivolumab can cause hair loss as a rare side effect.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.